"I have worked in the medical device business for 30 years, and as an entrepreneur in the field for the last 15 years, seeking out opportunities to improve patient healthcare and create outstanding value for shareholders. Often this work has been focused on producing a better, more efficient tool for use in the operating room. The improvements in health care delivery have been important, but relatively small, yet the businesses have been financially successful. When I was approached by Flying Brands to become their COO, and the CEO of their operating businesses, what immediately struck me was the opportunity to be the architect in the way that healthcare is delivered. This is an opportunity for a leap in healthcare, not the creeping change I have previously successfully delivered. A healthcare revolution, not the evolution I have previously managed. Imagine a world where expensive and invasive medical treatments are only used on patients that truly need it. Currently, resource consuming and painful biopsies are sought to confirm the presence or absence of disease in the face of ambiguous results from medical imaging. In an average hospital, hundreds of scans are taken daily, searching for disease. Imagine a software that is capable of detecting diseased patients and differentiating them from healthy patients, allowing healthcare practitioners to focus their care on the patients that need it the most. Imagine a software that improves its diagnostic capability over time, becoming more intelligent with each successful diagnosis and providing this knowledge and 'Artificial Intelligence' to those responsible for our healthcare. I believe that Flying Brands through its operating businesses, has the capability to develop the software able to deliver such a revolution ".
RE: Trans carried out by MM or MM & PIs07 Sep 2018 11:24
99% of transactions on AIM listed shares go through the market makers. there are occasional transfers of shares from one holder to another that go from broker to broker but these tend to be for larger amounts.
Impressive indeed. TB is consistently very responsive to shareholders enquiries. He also always have significant skin in the game for the companies that he runs. Many other AIM directors could certainly take a leaf out of his book.
Yes, I agree we need to get to the bottom of the companies intentions going forward and what assets they actually own and the value of these assets are calculated. I have never come across a company so adverse to promotion. It’s almost as if they don’t want shareholders to buy in and yet the directors own a decent percentage themselves so it is their interests that the share price rises.
Yes, I thought it was a good interview and David has a clear plan to hit the ground running and understands how the budgets work within the prospective client base and is tailoring the product accordingly. Stonechecjer have stated previously that they want their product to become the industry standard and the lower fee and consequent barrier to entry will obviously assist this. David appears to have an excellent track record in building sales in medical businesses which leaves me rather excited about the prospects here
Their model as i understand it is that, where possible, the PLC (or possibly now the newly incorporated Marechale Investments which is wholly owned by the PLC) take part payment in equity in the project they are providing funding for. Aside from the solar project the company have never been clear about what else they have equity in. All we have is the amounts mentioned in Investments for sale which may or may not represent the value of their share per the last funding round. My guess is that the new Investment company will be used to house all of the investments going forward and possibly beef up this side of the business. However, in the absence of any commentary from the company other than to pour cold water on any optimism we are left, as ever, in the dark.
They will probably try to find some way of dampening things. Look at the results, in previous years they have mentioned about seeking equity as part payment of their fees and yet this year nothing is mentioned despite them concluding their highest profile deal in recent history and securing equity in it!